How much liquid iron solution should be administered to a patient with a ferritin level of 7 ng/mL?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Oral Iron Dosing for Ferritin of 7 ng/mL

For an adult patient with a ferritin of 7 ng/mL, administer 65 mg of elemental iron in liquid form (ferrous sulfate or ferrous gluconate) once daily or every other day, preferably at bedtime on an empty stomach. 1

Dosing Algorithm

Adult Dosing

  • Standard dose: 65 mg elemental iron once daily or every other day 1
  • Timing: Take at bedtime for optimal brain iron transport 1
  • Food: Take on empty stomach (at least 2 hours after eating) for maximum absorption 2
  • Enhancement: Consider adding 100-200 mg vitamin C with each dose to increase absorption 1

Pediatric Dosing (if applicable)

  • Standard dose: 2-3 mg/kg/day of elemental iron in divided doses 2
  • Alternative: 3 mg/kg once daily or every other day before bed 1

Liquid Iron Formulations

The most common liquid iron preparations contain:

  • Ferrous sulfate solution: Most studied and cost-effective 2
  • Ferrous gluconate liquid: Well-tolerated alternative 3

Important: Liquid iron preparations can cause tooth staining—advise patient to take with a straw and rinse mouth after administration 1

Critical Considerations

Absorption Optimization

  • Alternate-day dosing may be superior to daily dosing because iron absorption decreases for 48 hours after each dose due to hepcidin elevation 1
  • Avoid taking within 2 hours of calcium, magnesium, caffeine, or food 1
  • If gastrointestinal side effects occur, can take with food despite reduced absorption 1

Monitoring

  • Recheck ferritin in 3 months to ensure levels have risen appropriately 1
  • If ferritin remains low or symptoms persist after 3 months of oral therapy, consider intravenous iron 1

When to Consider IV Iron Instead

With a ferritin of 7 ng/mL, strongly consider intravenous iron if: 1

  • Patient has gastrointestinal disease or prior bariatric surgery preventing absorption
  • Severe symptoms requiring rapid response
  • Known intolerance to oral iron
  • Ongoing blood loss

Common Pitfalls

  • Do not give more than 65 mg elemental iron per dose—higher doses do not improve absorption and increase side effects 1
  • Do not dose more frequently than once daily (preferably every other day)—this actually reduces total iron absorbed 1
  • Avoid aluminum-based phosphate binders which reduce iron absorption 2
  • Discontinue oral iron 48 hours before rechecking iron studies for accurate measurements 1

Tolerability Strategies

If patient experiences gastrointestinal side effects: 2

  • Start with lower dose and increase gradually
  • Switch to alternate-day dosing
  • Try different formulation (ferrous gluconate vs. ferrous sulfate)
  • Take at bedtime
  • Take with small amount of food (accepting reduced absorption)

Underlying Cause Investigation

With ferritin this low (7 ng/mL), investigate for: 1, 4

  • Menstrual blood loss (if premenopausal woman)
  • Gastrointestinal bleeding (upper or lower)
  • Malabsorption (celiac disease, H. pylori, atrophic gastritis)
  • Dietary insufficiency (vegan diet)
  • Medication effects (proton pump inhibitors, H2 blockers)
  • Frequent blood donation

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.